Goel R K, Lal Harbans
Departments of Medicine and Biochemistry, Maharaja Agrasen Medical College, Hisar, Agroha, 125047 Haryana India.
Indian J Clin Biochem. 2011 Jan;26(1):88-90. doi: 10.1007/s12291-010-0092-0. Epub 2010 Dec 29.
Role of Vitamin D supplementation was studied in patients with hypertension. One hundred hypertensive patients (group I) were given conventional antihypertensive drugs while another 100 patients (group II), in addition, were supplemented with Vitamin D(3) (33,000 IU, after every 2 weeks, for 3 months). Besides diastolic and systolic blood pressure, serum calcium, phosphorous, alkaline phosphatase, albumin, albumin-corrected calcium, and 24 h urinary creatinine levels were estimated in both the groups before the start of treatment and after 3 months. Vitamin D supplementation showed a more significant decrease in systolic blood pressure. This group also showed a significant increase in serum calcium as well as albumin-corrected calcium with a decrease in phosphorous. Results of the study confirm that Vitamin D supplementation has a role in reducing blood pressure in hypertensive patients and that it should be supplemented with the antihypertensive drugs. More extensive studies with a larger group, to draw a definite conclusion, are in progress.
研究了补充维生素D在高血压患者中的作用。100名高血压患者(第一组)服用传统抗高血压药物,而另外100名患者(第二组)除服用传统抗高血压药物外,还补充维生素D3(每2周33,000国际单位,共3个月)。在治疗开始前和3个月后,两组均测定了舒张压和收缩压、血清钙、磷、碱性磷酸酶、白蛋白、白蛋白校正钙和24小时尿肌酐水平。补充维生素D后收缩压下降更为显著。该组血清钙以及白蛋白校正钙也显著升高,磷降低。研究结果证实,补充维生素D在降低高血压患者血压方面有作用,应与抗高血压药物一起补充。目前正在进行更广泛的研究,纳入更大的群体,以得出明确结论。